Alpha Tau Medical Ltd


Prices are adjusted according to historical splits.

Alpha Tau Medical Ltd Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$325.60 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Alpha Tau Medical Ltd had its IPO on 2021-03-08 under the ticker symbol DRTS.

The company operates in the Healthcare sector and Biotechnology industry. Alpha Tau Medical Ltd has a staff strength of 94 employees.

Stock update

Shares of Alpha Tau Medical Ltd opened at $3.35 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.3 - $3.43, and closed at $3.34.

This is a -0.3% slip from the previous day's closing price.

A total volume of 9,451 shares were traded at the close of the day’s session.

In the last one week, shares of Alpha Tau Medical Ltd have slipped by -6.96%.

Alpha Tau Medical Ltd's Key Ratios

Alpha Tau Medical Ltd has a market cap of $325.60 million, indicating a price to book ratio of 2.2584 and a price to sales ratio of 0.

In the last 12-months Alpha Tau Medical Ltd’s revenue was $0 with a gross profit of $0 and an EBITDA of $-31157000. The EBITDA ratio measures Alpha Tau Medical Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Alpha Tau Medical Ltd’s operating margin was 0% while its return on assets stood at -24.74% with a return of equity of -47.07%.

In Q1, Alpha Tau Medical Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Alpha Tau Medical Ltd’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.13 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alpha Tau Medical Ltd’s profitability.

Alpha Tau Medical Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -4.7898. Its price to sales ratio in the trailing 12-months stood at 0.

Alpha Tau Medical Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$7.89 million
Total Liabilities
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Alpha Tau Medical Ltd ended 2024 with $7.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $7.89 million while shareholder equity stood at $-48250.00.

Alpha Tau Medical Ltd ended 2024 with $0 in deferred long-term liabilities, $337250.00 in other current liabilities, in common stock, $-4171750.00 in retained earnings and $0 in goodwill. Its cash balance stood at $457750.00 and cash and short-term investments were $7.03 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Alpha Tau Medical Ltd’s total current assets stands at $7.46 million while long-term investments were $0 and short-term investments were $6.57 million. Its net receivables were $141000.00 compared to accounts payable of $223250.00 and inventory worth $0.

In 2024, Alpha Tau Medical Ltd's operating cash flow was $0 while its capital expenditure stood at $226000.

Comparatively, Alpha Tau Medical Ltd paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Alpha Tau Medical Ltd stock is currently trading at $3.34 per share. It touched a 52-week high of $12.5 and a 52-week low of $12.5. Analysts tracking the stock have a 12-month average target price of $15.

Its 50-day moving average was $3.75 and 200-day moving average was $3.6 The short ratio stood at 2.7 indicating a short percent outstanding of 0%.

Around 4543.7% of the company’s stock are held by insiders while 164.9% are held by institutions.

Frequently Asked Questions About Alpha Tau Medical Ltd

The stock symbol (also called stock or share ticker) of Alpha Tau Medical Ltd is DRTS

The IPO of Alpha Tau Medical Ltd took place on 2021-03-08

Similar Industry Stocks (Biotechnology)

Last Price
Public Storage (PSA-PN)
HT Media Limited (HTMEDIA)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.


5 Kiryat Hamada Street, Jerusalem, Israel, 9777605